Yongxin Han Selected Research

Piperidines

12/2011	Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of spirocyclic piperidines.
7/2011	Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of tertiary alcohol-bearing piperidines.
7/2011	Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of pyridone-substituted piperidines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yongxin Han Research Topics

Disease

9	Neoplasms (Cancer) 04/2021 - 05/2004
5	Inflammation (Inflammations) 09/2009 - 05/2004
4	Pain (Aches) 09/2012 - 05/2008
3	Hypertension (High Blood Pressure) 12/2011 - 07/2011
2	Rheumatoid Arthritis 07/2008 - 05/2008
2	Carcinogenesis 08/2007 - 03/2007
1	Pulmonary Hypertension 03/2020
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 03/2020
1	Hypothermia 03/2020
1	Hypersensitivity (Allergy) 10/2018
1	Nervous System Diseases (Neurological Disorders) 10/2018
1	Stomach Ulcer (Gastric Ulcer) 10/2018
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2017
1	Infections 03/2014
1	Hyperalgesia 05/2008
1	Osteoarthritis 05/2008
1	Arthritis (Polyarthritis) 05/2008
1	Arthralgia (Joint Pain) 05/2008
1	Colonic Neoplasms (Colon Cancer) 08/2007
1	Neoplasm Metastasis (Metastasis) 03/2007
1	Ischemia 05/2004
1	Huntington Disease (Huntington's Disease) 02/2004
1	Sepsis (Septicemia) 01/2004
1	Brain Injuries (Brain Injury) 08/2002

Drug/Important Bio-Agent (IBA)

4	ProstaglandinsIBA 01/2021 - 08/2007
3	Phosphotransferases (Kinase)IBA 01/2017 - 08/2007
3	PiperidinesIBA 12/2011 - 07/2011
3	Renin InhibitorsIBA 12/2011 - 07/2011
2	quinolineIBA 02/2011 - 03/2008
2	Prostaglandins EIBA 07/2008 - 08/2007
2	Caspase 3 (Caspase-3)IBA 02/2004 - 08/2002
2	CaspasesIBA 01/2004 - 08/2002
1	Dinoprostone (PGE2)FDA Link 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2021
1	Interleukin-2 (IL2)IBA 01/2021
1	Arachidonic Acid (Vitamin F)IBA 01/2021
1	pembrolizumabIBA 01/2021
1	Biological ProductsIBA 01/2020
1	AntibodiesIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Histamine (Histamine Dihydrochloride)FDA Link 10/2018
1	elbasvirIBA 03/2014
1	grazoprevirIBA 03/2014
1	Protease Inhibitors (Protease Inhibitor)IBA 03/2014
1	tyrosine receptor (receptor, tyrosine)IBA 09/2012
1	naphthaleneIBA 02/2011
1	Benzoic Acid (Potassium Benzoate)FDA Link 06/2010
1	MF-310IBA 09/2009
1	Pharmaceutical PreparationsIBA 05/2008
1	Diclofenac (SR 38)FDA LinkGeneric 05/2008
1	CollagenIBA 05/2008
1	Prostaglandin-E SynthasesIBA 05/2008
1	3- (3,4- difluorophenyl)- 4- (4- (methylsulfonyl)phenyl)- 2(5H)- furanoneIBA 05/2008
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2008
1	acetamideIBA 05/2008
1	L-161982IBA 08/2007
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2007
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 03/2007
1	Neuroprotective AgentsIBA 02/2004
1	malonic acid (malonate)IBA 02/2004
1	Caspase InhibitorsIBA 01/2004
1	CalpainIBA 08/2002
1	Peptides (Polypeptides)IBA 08/2002

Therapy/Procedure

5	Therapeutics 01/2021 - 01/2004
4	Immunotherapy 03/2021 - 11/2019
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 04/2021
1	Deep Hypothermia Induced Circulatory Arrest 04/2021
1	Sternotomy 03/2020
1	Endarterectomy (Thromboendarterectomy) 03/2020
1	Biological Therapy 01/2020